The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Biochemical aspects of Parkinson's disease
Abstract
The importance of the striatal dopamine (DA) deficiency and the DA substituting property of levodopa for the pathophysiology and therapy of Parkinson's disease (PD) is reiterated. In addition, it is shown that in PD, significantly reduced DA levels are also found in the nucleus accumbens, external and internal segments of the globus pallidus, the substantia nigra reticulata, and the subthalamic nucleus. It is proposed that, in addition to the critical role played by the striatal DA loss, the DA changes in the extrastriatal nuclei of the basal ganglia are importantly involved in the pathophysiologic mechanisms resulting in the parkinsonian movement disorder, and that the therapeutic and/or side effects of DA substitution therapy may, in part, be mediated through these brain regions which, like the striatum, suffer DAergic deafferentation in PD. From observations in brain of patients with secondary parkinsonism, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine parkinsonism in the rhesus monkey, as well as the regional DA transporter distribution in the primate substantia nigra, it is concluded that PD may be caused by any exogenous and/or endogenous toxin using the transporter system for DA and to some degree the other brain monoamines (noradrenaline, serotonin), to enter, and damage, the respective monoamine neurons. Based on converging evidence, the view is advanced that endogenous, genetically based (excessive) formation, or accumulation, of toxic DA transporter substrates, such as isoquinoline or beta-carboline derivatives, may in fact represent the primary cause of substantia nigra cell degeneration in patients with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Aromatic Amino Acids and Modification of Parkinsonism
Cotzias, G. C., Van Woert, M. H., & Schiffer, L. M. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760703 · Cited by 1,494
The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
David Smith, A., & Paul Bolam, J. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,036
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 849
Self-citationFunctional and pathophysiological models of the basal ganglia
Wichmann, T., & DeLong, M. R. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80024-9 · Cited by 731
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Yung, K. K. L., Bolam, J. P., Smith, A. D., Hersch, S. M., Ciliax, B. J., & Levey, A. I. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00536-e · Cited by 542
Localization of dopamine D4 receptors in GABAergic neurons of the primate brain
Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R., & Goldman-Rakic, P. S. (1996) · Nature · doi:10.1038/381245a0 · Cited by 494
Nirenberg, M., Vaughan, R., Uhl, G., Kuhar, M., & Pickel, V. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00436.1996 · Cited by 480
Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats
Ernst, A. M., & Smelik, P. G. (1966) · Experientia · doi:10.1007/bf01897450 · Cited by 329
Differential diagnosis between radiation and tumor plexopathy of the pelvis
Thomas, J. E., Cascino, T. L., & Earle, J. D. (1985) · Neurology · doi:10.1212/wnl.35.1.1 · Cited by 294
Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
Fisher, B., Redmond, C., Brown, A., Wolmark, N., Wittliff, J., Fisher, E. R., Plotkin, D., Bowman, D., Sachs, S., Wolter, J., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050101 · Cited by 287
Richfield, E. K., Young, A. B., & Penney, J. B. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902620308 · Cited by 263
Fahn, S., Libsch, L. R., & Cutler, R. W. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90178-x · Cited by 224
Wilson, J. M., Levey, A. I., Rajput, A., Ang, L., Guttman, M., Shannak, K., Niznik, H. B., Hornykiewicz, O., Pifl, C., & Kish, S. J. (1996) · Neurology · doi:10.1212/wnl.47.3.718 · Cited by 222
Self-citationRenal-dose dopamine: a Siren song?
Thompson, B., & Cockrill, B. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91044-8 · Cited by 125
Nisbet, A. P., Föster, O., Kingsbury, A. E., Eve, D. J., Daniel, S. E., MARSDEN, C. D., & Lees, A. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00606-6 · Cited by 115
Late‐onset Hallervorden‐Spatz disease presenting as familial parkinsonism
Jankovic, J. J., Kirkpatrick, J. B., Blomquist, K. A., Langlais, P. J., & Bird, E. D. (1985) · Neurology · doi:10.1212/wnl.35.2.227 · Cited by 108
Uncertainty in Identification of Blood Group A Subtypes by Agglutination Test
Yoshida, A., eacute, V. D., & Prchal, J. T. (1985) · Human Heredity · doi:10.1159/000153505 · Cited by 98
Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
Couteur, D. G. L., Leighton, P. W., McCann, S. J., & Pond, S. M. (1997) · Movement Disorders · doi:10.1002/mds.870120523 · Cited by 95
Thirty years of dopamine research.
Carlsson, A. (1993) · PubMed · Cited by 88
Dopamine attenuates the effects of GABA on single unit activity in the Globus pallidus
Bergstrom, D. A., & Walters, J. R. (1984) · Brain Research · doi:10.1016/0006-8993(84)90006-4 · Cited by 69
Overview: The biology of varicella-zoster virus infection
Straus, S. E. (1994) · Annals of Neurology · doi:10.1002/ana.410350704 · Cited by 59
Crook, J. M., Eysel, U. T., & Machemer, H. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90169-o · Cited by 54
Neurophysiology of fastest voluntary muscle contraction in hereditary neuropathy
Logigian, E. L., Hefter, H., Reiners, K., & Freund, H. (1990) · Annals of Neurology · doi:10.1002/ana.410270103 · Cited by 42
The history of veterinary medicine in Alabama, 1892-1952.
Ed, S. (1990) · PubMed · Cited by 42
Kanazawa, I., Kwak, S., Sasaki, H., Muramoto, O., Mizutani, T., Hori, A., & Nukina, N. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90020-2 · Cited by 35
Disability care and education in 19th century India: some dates, places and documentation.
Miles, M. (1994) · PubMed · Cited by 24
Brain monoamines in progressive supranuclear palsy — comparison with idiopathic Parkinson’s disease
Hornykiewicz, O., & Shannak, K. S. (1994) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6641-3_17 · Cited by 18
Self-citationDemographic intermediation between development and population redistribution in Sudan
Farah, A. A. M. (1985) · Cambridge University Press eBooks · doi:10.1017/cbo9780511898402.017 · Cited by 11
Fahn, S., & MARSDEN, C. D. (1995) · Movement Disorders · doi:10.1002/mds.870100102 · Cited by 11
Cited by
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012
“The Molecular Mechanisms of Neuron Soma and Axon Degeneration Are Distinct The concept that axons may be involved early in the course of PD is not new; it was proposed by Hornykiewicz years ago when he suggested that in PD, neurodegeneration may be a dying-back process that begins in the striatal terminals.(49) Our pu…”
BackgroundDopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Carta, M., Carlsson, T., Kirik, D., & Bjorklund, A. (2007) · Brain · doi:10.1093/brain/awm082 · Cited by 636
Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585
Lee, C. S., Samii, A., Sossi, V., Ruth, T. J., Schulzer, M., Holden, J. E., Wudel, J., Pal, P. K., De La Fuente-Fernandez, R., Calne, D. B., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<493::aid-ana13>3.0.co;2-4 · Cited by 580
Axon degeneration in Parkinson's disease
Burke, R. E., & O'Malley, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 493
Metadata
- Authors
- Hornykiewicz, O.
- Venue
- Neurology
- Published
- 1998-08
- Volume
- 51
- Issue
- 2_suppl_2
- Pages
- S2-9
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2112648950
- Cited by
- 564
- References
- 32
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.